Cells were lysed in RIPA buffer plus protease inhibitors (leupeptin 1 μg/mL, aprotinin 1 μg/mL, PMSF 100 μg/mL and EDTA 1 mM) and 0.5 mM N-ethylmaleimide (NEM). Equal amount of total proteins were resolved by SDS-PAGE under reducing conditions, and immunoblotted with the indicated antibodies: anti-UBC9 (Abcam), anti-SUMO1 (Sigma-Aldrich), anti-SUMO2/3 (Abcam), anti-RanGAP1 (Santa Cruz Biotechnology), anti-p53 (DO-1; Santa Cruz Biotechnology), anti-pRb (Santa Cruz Biotechology), anti-SAE1 (Abcam), anti-SAE2 (Abcam), anti-Ubiquitylated proteins (FK1, Biomol), anti-LC3 (Novus Biologicals), anti-p62 (2C11, Abnova), anti-EGFR (kindly provided by S. Sigismund, Fondazione Istituto FIRC di Oncologia Molecolare, IFOM, Milan [86 (link)]), anti-ATG5 (Cell Signaling Technology), anti-pRb (BD Pharmingen). Anti-GAPDH (Abcam), anti-tubulin (Sigma-Aldrich), or anti-vinculin (Santa Cruz Biotechnology) antibodies were used as loading control. Membranes were then incubated with the appropriate IR Dye-conjugated or horseradish peroxidase (HRP) secondary antibodies (Licor), and scanned with a LI-COR Odyssey Imager or acquired with Chemidoc (Bio-rad), respectively. The intensities of the protein bands were quantified using ImageJ software (Rasband W.S., ImageJ, U. S. National Institutes of Health), and standardized to the housekeeper levels.
Free full text: Click here